Chief Business Officer of Tracon Pharmaceuticals, Inc. (NASDAQ:TCON), Wiggins Mark C, buys 1,000 shares worth $10,570
According to Tracon Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 06:00 AM, company Chief Business Officer, Wiggins Mark C disclosed buying 1,000 shares at a cost of $10.57. At the time of this transaction (Dec 29), this trade was worth $10,570 in total. As of Dec 29, Wiggins Mark C now owns 13,700 shares in total worth about $145,768.0.
For the last few recent trades made by Tracon Pharmaceuticals, Inc. (NASDAQ:TCON) Chief Business Officer, Wiggins Mark C, we have the following information:
- SEC Form 4 filing: Sep 10: Bought 7,000 shares at the rate of $4.14 per share. Total worth of this trade was $28,953. Total number of shares owned as of Sep 10 were 12,350
- SEC Form 4 filing: Jan 23: Bought 5,000 shares at the rate of $4.02 per share. Total worth of this trade was $20,103. Total number of shares owned as of Jan 23 were 5,000
Posted by
George Daniels
on Wednesday December 30 2020, 10:03 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
